Skip to main content
. 2021 Aug 25;26(12):1044–1051. doi: 10.1002/onco.13934

Table 1.

Demographic and clinical‐pathologic features for women with endometrial cancer

Clinicopathologic factor n (%)
Age at surgery, yr
Mean (SD) 61.59 (10.92)
Median 62
<60 316 (41)
≥60 455 (59)
BMI
Mean (SD) 38.02 (10.38)
Median 36.9
<25 68 (8.8)
≥25–30 106 (13.7)
≥30–35 157 (20.4)
≥35 440 (57.1)
Race
White 725 (94)
Black 30 (3.9)
Other 16 (2.1)
Histology
Endometrioid 632 (82)
Serous 55 (7.1)
Mixed 40 (5.2)
Carcinosarcoma 22 (2.9)
Undifferentiated/dedifferentiated 12 (1.6)
Mucinous 6 a (0.8)
Clear cell 4 (0.5)
FIGO grade, endometrioid only
1 517 (81.8)
2 78 (12.3)
3 37 (5.9)
Stage
I 613 (79.5)
II 22 (2.9)
III 100 (13)
IV 36 (4.7)
Adjuvant therapy received
Yes 229 (29.7)
No 542 (70.3)
MMR status
Intact 588 (76.3)
Deficient 174 (22.6)
Unknown 9 (1.2)
a

All mucinous histologies were grade 1.

Abbreviations: BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; MMR, mismatch repair.